All articles tagged with #myocarditis
Hirata Runa, an eight-year-old trainee for the Japanese idol group DIANNA Project, died on September 25, 2026, from myocarditis caused by influenza. She had performed her final concert just five days prior. Her family and agency requested privacy during the mourning period, noting that a third of her life was spent in the entertainment industry.
Hirata Runa, an 8-year-old trainee for the Japanese idol group DIANNA Project, died on September 25, 2026. Her agency confirmed the cause of death was myocarditis resulting from an influenza infection. Runa had performed her final concert just five days prior to her passing.
Hirata Runa, an 8-year-old trainee for the Japanese idol group DIANNA Project, died on September 25, 2026. Her agency confirmed the cause of death was myocarditis resulting from an influenza infection. Runa had performed her final concert just five days prior to her passing.
A 37-year-old healthy man suffered sudden cardiac arrest due to perimyocarditis, a rare inflammatory condition that mimics a heart attack. Despite clear coronary arteries, he experienced ventricular fibrillation and cardiogenic shock. Cardiac MRI confirmed the diagnosis, and he fully recovered his heart function with treatment.
A large retrospective study of about 4.1 million people aged 16–25 found that Pfizer/BNT162b2 vaccination is associated with lower risk of myocarditis, pericarditis, and death than SARS-CoV-2 infection; infection carries a higher cardiac risk than vaccination, though vaccine-associated myocarditis remains rare.
An op-ed analyzing a December 2025 FDA OBPV post-market safety review argues that, while myocarditis after mRNA COVID vaccines is a real and rare risk, the 96 pediatric deaths reviewed were not proven to be vaccine-caused and did not reveal a hidden FDA effort to conceal deaths; using the WHO-UMC causality framework, most cases were deemed unlikely or unassessable, with only a few probable or possible links largely tied to alternate explanations. The report recommends a safety-labeling update (Boxed Warning, updated Warnings/Precautions, Adverse Reactions, and Patient Insert) but stops short of a benefit-risk conclusion, contrary to political framing that labeled it a scandal.
The FDA reviewed 96 VAERS reports of child deaths through Aug. 14, 2025 and found no cases definitively linked to Covid vaccines; five were labeled possible and two probable, but causality could not be ruled out and VAERS limitations apply. The analysis, prompted by ongoing vaccine safety discussions, notes that most cases involved myocarditis and that infections can also trigger this condition.
An Op-Ed argues that the reconstituted ACIP is relitigating COVID vaccine safety using an unvalidated PACVS framework, proposing unvalidated diagnostics and dubious prevalence, while ignoring robust VSD surveillance showing no excess mortality post-vaccination; internal dissent among work-group members and a court ruling suggesting the process violated the Administrative Procedure Act highlight concerns that policy is being guided by conclusions rather than evidence. The piece warns that replacing GRADE with a weaker evidentiary standard would undermine vaccine policy across all vaccines, and notes the March meeting was postponed, set against a public health backdrop of measles outbreaks.
A landmark England-wide study of nearly 14 million under-18s found that COVID infection carries a substantially higher risk of inflammatory heart conditions (myocarditis and pericarditis) than vaccination, with vaccine-related risks being rare and short-lived (dissipating within a month) while infection-related risks can persist for up to a year, reinforcing vaccine safety messaging.
Stanford researchers have identified that rare cases of heart inflammation post-mRNA COVID-19 vaccination are driven by immune responses involving cytokines CXCL10 and IFN-gamma, and found that the soy-derived compound genistein may help reduce this inflammation, offering insights into safer vaccine strategies.
Stanford researchers have uncovered a biological mechanism explaining why rare cases of myocarditis occur after mRNA COVID-19 vaccination, identifying two cytokines, CXCL10 and IFN-gamma, as key drivers of heart inflammation, and suggesting that cytokine inhibitors or dietary supplements like genistein could potentially reduce this risk.
A Stanford study explains that myocarditis, a rare heart inflammation linked to COVID-19 vaccines, is caused by immune proteins CXCL10 and IFN-gamma. The research suggests that targeted immune modulation could reduce risk, especially in young males, without compromising vaccine benefits. The overall safety of COVID vaccines remains high, with myocarditis being a very rare side effect.
A Stanford study highlights a rare risk of myocarditis, or heart inflammation, associated with mRNA Covid-19 vaccines, especially in young men and children, with an estimated occurrence of 1 in 140,000 after the first dose and 1 in 32,000 after the second. While most recover quickly, the study emphasizes that Covid itself is more likely to cause myocarditis than the vaccine, and advises seeking medical help if chest pains occur post-vaccination.
A Stanford Medicine study indicates that mRNA COVID-19 vaccines can cause myocarditis, especially in young men and adolescents, with a very low incidence rate, but most cases recover fully and the benefits of vaccination outweigh the risks.
The FDA has expanded warnings on Pfizer and Moderna COVID-19 vaccines about a rare risk of myocarditis, especially in young males aged 12-24, with a rate of 8 cases per million doses in individuals aged 6 months to 64 years, amid ongoing debates over vaccine safety and policy.